Magnolia Medical Technologies today touted “unprecedented” results from a clinical study of its Steripath in sepsis testing. Seattle-based Magnolia Medical’s Steripath, a blood culture contamination product, was being evaluated for its impact in reducing false-positive blood culture results in sepsis testing, according to a news release. Results of the study were presented by Stanford Healthcare’s […]
Magnolia Medical Technologies
Magnolia Medical receives $20m venture loan facility
Horizon Technology Finance announced that it issued a $20 million venture loan facility to blood culture collection device maker Magnolia Medical. According to a news release, Horizon provided the loan facility to Magnolia on May 6 to support its FDA-cleared Steripath device for preventing the contamination of blood cultures upon collection. “Magnolia’s Steripath device has […]
UPDATE: Magnolia Medical files another suit against Kurin
Updated to include a response from Kurin. Magnolia Medical Technologies said yesterday that it filed another legal action against blood-culture-focused device developer Kurin, this time claiming the company has infringed on patents related to its Steripath technology. The Seattle-based company asserts that Kurin is infringing upon four patents related to its Steripath blood collection technology […]
Owens & Minor taps former Thermo Fisher CCO Pesicka as prez, CEO | Personnel Moves – February 27, 2019
Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]
Magnolia Medical closes $20m Series C
Magnolia Medical Technologies said today that it closed a $20 million Series C financing round slated to help grow the company’s infrastructure and market initiatives to meet demand for its Steripath Gen2 initial specimen diversion device. The next-generation device, launched last August, features mechanical initial specimen diversion and improved usability based on input from end […]
Magnolia Medical launches Steripath Gen2 system
Magnolia Medical Technologies said yesterday it launched its Steripath Gen2 blood collection system. The next-generation device features mechanical initial specimen diversion and improved usability based on input from end users, the Seattle-based company said. “Our team is very pleased with the 83 percent reduction in blood culture contamination we have achieved using Steripath. Based on this […]
Magnolia Medical, Kurin trade lawsuits
Magnolia Medical Technologies said yesterday it filed a lawsuit against blood-culture-focused device developer Kurin claiming the company “mischaracterized its clinical data as well as the functionality and ease of use of its device.” The suit comes in response to a similar suit filed by Kurin in the Southern District of California in May which claimed […]
Lombard Medical CEO Hubbert, CFO Kullback step down | Personnel Moves, April 28, 2017
Lombard Medical Technologies (NSDQ:EVAR) said this month that its CEO Simon Hubbert and CFO William Kullback are stepping down from their positions, with Kurt Lemvigh stepping into the CEO role. Hubbert served as CEO for 6 years after joining the company in 2010, and will be replaced by Lemvigh, who has held positions with multiple companies, including […]
Magnolia Medical raises $7m to support Steripath system
Magnolia Medical Technologies said today it raised $7.3 million in a new round of funding to support its Steripath blood collection system. The SteriPath vacuum-assisted blood collection system is designed to divert and sequester contaminants from the initial blood sample specimen to eliminate “false positive” blood culture test results from patients with suspected sepsis, the […]
Magnolia Medical raises $13.8m
Seattle-based Magnolia Medical Technologies said today it raised $13.8 million in a Series B round of financing to support the commercialization of its SteriPath blood collection system. Magnolia produces the SteriPath vacuum-assisted blood collection system designed to divert and sequester contaminants from the initial blood sample specimen, according to the company’s website. The SteriPath unit […]
Next-gen blood collection device maker Magnolia Medical raises $1.4m
Seattle-based Magnolia Medical Technologies brought in $1.4 million in a new round of debt financing and looks to bring in another $1.6 million before closing the round, according to an SEC filing posted last week. Magnolia produces the SteriPath vacuum-assisted blood collection system designed to divert and sequester contaminants from the initial blood sample specimen, […]
